Study of clinical symptoms, comorbidities and hospitalization among COVID-19 patients in telemedicine utilizers
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20221754Keywords:
Telemedicine Services, Comorbidities, COVID-19, HospitalizationAbstract
Background: COVID-19, in those with comorbidities, has an increasingly rapid and severe progression, often leading to death. Telemedicine services provided by the tertiary care centre contributed to decrease the burden of mortality and morbidity patterns by providing the health services during this pandemic. To determine the clinical symptoms in the COVID-19 patients. To estimate the comorbidities in the COVID-19 patients. To find the association between comorbidity and hospitalization among the COVID-19 patients
Methods: A descriptive cross-sectional study was conducted among the population who availed for the services of telemedicine. Among the total call data of 9229 a sample of 8638 was obtained. Simple random sampling method used with the help of a pre-designed and pre-tested questionnaire. Data was analyzed using MS excel, SPSS version 19.
Results: Demographic profile of the study population of 8638, Males 5862 (67.86%), Females 2776 (32.13%). It shows significant association between symptoms and RTPCR test results. (X2 =12.0 df=1 p=0.0005), Majority of patients presented with comorbidities like diabetes and hypertension and there is significant association between comorbidity and hospitalization. (X2=8.3 df=1 p=0.003)
Conclusions: Screening and health education of people with comorbidity regarding clinical symptoms and RTPCR testing of COVID-19 is very crucial for early diagnosis and intervention. Telemedicine services by various NGO’s, Tertiary care hospitals have contributed in providing services with the aim of decreasing the morbidity and mortality due to COVID-19.
References
Jakhmola S, Indari O, Baral B, Kashyap D, Varshney N, Das A, et al. Comorbidity assessment is essential during COVID-19 Treatment. Front Physiol. 2020;11: 984.
Coronavirus (COVID-19): symptoms of coronavirus. Available at: https://www.cdc.gov/coronavirus/2019-ncov/ symptoms-testing/symptoms.html. Accessed on 20 April 2020.
Magdy R, Hussein M, Ragaie C, Abdel-Hamid HM, Khallaf A, Rizk HI, et al. Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: A cross sectional study. Cephalalgia. 2020;40(13):1422-31.
Martínez-García M, Bal-Alvarado M, Santos Guerra F, Ares-Rico R, Suárez-Gil R, Rodríguez-Álvarez A, et al. Monitoring of COVID-19 patients via telemedicine with telemonitoring. Rev Clin Esp. 2020; 220:472-9.
Sanyaolu A, Okorie C, Marinkovic A. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020;2:1069-76.
Singh AK, Misra A. Impact of COVID-19 and comorbidities on health and economics: focus on developing countries and India. Diabetes, Metab Syndrome: Clin Res Rev. 2020;14(6):1625-30.
Mohamed Hussein AA, Saad M, Zayan HE, Abdelsayed M, Moustafa M, Ezzat AR, et al. Post-COVID-19 functional status: Relation to age, smoking, hospitalization, and previous comorbidities. Ann Thorac Med. 2021;16:260-5.
Egede J, Campbell JA, Walker RJ, Garacci E, Dawson AZ, Egede LE. Relationship between physical and mental health comorbidities and COVID-19 positivity, hospitalization, and mortality. J Affect Disord. 2021; 283:94-100.
Nagra MH, Ehsan S, Ahmad U, Ali M, Hussain HA, Bakar A. Implementation of a telemedicine service during COVID-19 pandemic in Pakistan. Int J Clin Pract. 2021;75(12):e14925.
Rabady S, Hoffmann K, Brose M, Lammel O, Poggenburg S, Redlberger-Fritz M, et al. Symptoms and risk factors for hospitalization of COVID-19 presented in primary care: An exploratory retrospective study. Wien Klin Wochenschr. 2022;14: 1-9.
Jain V, Yuan JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020;65(5):533-46.
Suleyman G, Fadel RA, Malette KM. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Netw Open. 2020;3(6): e2012270.
Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833-9.
Wohl DA, Barzin AH, Napravnik S, Davy-Mendez T, Smedberg JR, Thompson CM, et al. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2. PLoS ONE. 2021;16(12): e0260879.
Krishnasamy N, Natarajan M, Ramachandran A, Vivian Thangaraj JW, Etherajan T, Rengarajan J, et al. Clinical outcomes among asymptomatic or mildly symptomatic COVID-19 patients in an isolation facility in Chennai, India. Am J Trop Med Hyg. 2021; 104(1):85-90.
Sabatino J, De Rosa S, Di Salvo G, Indolfi C. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PLOS One. 2020;15(8):e0237131.
